COMING SOON: Hypothesize That! – a new science podcast from ��ֳ�

Vandenbruaene Nathalie — Mon, 24 Feb 2025 13:11:01 +0000

Scott Fleming, Corporate Communication

Vandenbruaene … Mon 24/02/2025 - 14:11

Hypothesize That! brings together thought leaders, researchers, and visionaries to redefine the future of drug discovery and development. Whether you're an industry professional or a science enthusiast, this podcast promises to spark curiosity and inspire innovation!

Curious about how cutting-edge innovations and bold ideas are reshaping the pharmaceutical landscape? The Hypothesize That! podcast is your gateway to unearthing the trends, theories, and challenges at the forefront of pharmaceutical research and development.

Where science meets conversation

What sets Hypothesize That! apart? Featuring guest appearances by leading voices across the industry, it’s more than a podcast – it's an exchange of ideas to make you think.

What you can expect

About the host
Nicola Hill is an experienced health journalist and TV presenter with more than 30 years of expertise developing a sharp instinct in uncovering compelling stories.

A sneak peek at episodes 1-3

Episode 1: The end of wet labs? How digital is virtualizing pharma research

Russ Altman, Professor from Stanford University and host of the Future of Everything podcast, and ��ֳ�’s Chief Scientific Officer, Alistair Henry interrogate the role of AI in revolutionizing drug discovery and experimentation

Episode 2: Within the next 10 years, will traditional clinical trials be obsolete?

Craig Lipset (Co-Chair of the Decentralized Trials and Research Alliance) and Lewis Millen (Global Clinical Science and Operations Innovation, ��ֳ�) explore the rise of decentralized clinical trials that operate invisibly in participants' daily lives, altering the future of clinical trials

Episode 3: Gene therapy’s future: will patient engagement eclipse science?

Emma Lane (Gene Therapy Patient Engagement Lead, ��ֳ�) and Laurence Woollard (patient advocate and Director of On the Pulse) examine why early and ongoing collaboration with patients might be the key factor driving the success of gene therapies.

Be the first to listen

Hypothesize That! will be available on Spotify and your favorite podcast platforms. Don’t miss the opportunity to stay ahead of the curve in pharmaceutical innovation.

Be sure to follow us on LinkedIn for updates, exclusive content, and a few surprises. The future of pharma starts here – Hypothesize That! is your front-row seat to the conversation.

innovation

Podcast research & development Hypothesize That!

168 Likes

Driving innovation forward: ��ֳ� unveils new R&D facility

Vandenbruaene Nathalie — Mon, 10 Feb 2025 09:52:39 +0000

Driving innovation forward: ��ֳ� unveils new R&D facility

Luc Uylenbroeck, External Innovation and Operations

Vandenbruaene … Mon 10/02/2025 - 10:52

I am thrilled to announce the start of the construction of a state-of-the-art research & development (R&D) facility at our Braine-l’Alleud Campus. The new facility, known as the Arkelia project is a milestone of our long-term strategy to push the boundaries of science and deliver life-changing solutions for people living with severe diseases worldwide.

Designed to connect seamlessly with the company’s gene therapy center and key neurology research infrastructure, Arkelia will foster collaboration, accelerate advancements in research and development, and drive innovation in manufacturing. With a research focus on neurodegeneration, neuroinflammation, epilepsy, and early-stage development, this facility will strengthen ��ֳ�’s global leadership in pioneering solutions for patients.

Accommodating more than 170 scientists, the facility is built to encourage cross-disciplinary collaboration while leveraging cutting-edge technology and advanced scientific tools to enhance R&D capabilities. More than just a workspace, it will serve as a dynamic ecosystem that fosters scientific creativity and accelerates the development of transformative therapies.

Crucially, Arkelia underscores ��ֳ�’s unwavering commitment to sustainability. Designed to the highest eco-standards, the facility will incorporate energy-efficient systems, renewable energy sources, and sustainable materials to minimize its environmental footprint. By integrating green technologies, we are ensuring that scientific advancement goes hand in hand with environmental responsibility.

This initiative significantly contributes to the growth strategy of the Braine-l'Alleud Campus, reinforcing collaboration between research, development, manufacturing, and supply teams. The facility’s flexible and forward-thinking design will align critical phases of innovation, ensuring accelerated progress while prioritizing sustainability.

Set to become fully operational by 2028, Arkelia marks a significant milestone in ��ֳ�’s sustainable growth journey. It reflects our ongoing dedication to delivering high-impact solutions while upholding our responsibility to the planet.

Stay tuned for more updates as we continue to drive innovation forward at ��ֳ�.

innovation

R&D research & development Arkelia Braine-l’Alleud

132 Likes

research & development

COMING SOON: Hypothesize That! – a new science podcast from ��ֳ�

Leave a Comment

Driving innovation forward: ��ֳ� unveils new R&D facility

Leave a Comment

research & development

COMING SOON: Hypothesize That! – a new science podcast from ������ֳ�

Leave a Comment

Driving innovation forward: ������ֳ� unveils new R&D facility

Leave a Comment

COMING SOON: Hypothesize That! – a new science podcast from ��ֳ�

Driving innovation forward: ��ֳ� unveils new R&D facility